Genmab — November 2020

E_L

and it seems
manageable

GeorgeBest

Nordea think the liver side-effects may hinder going to high doses!

E_L

that would make sense. maybe that is something we can hear about on friday. But from the data we saw today, i found it hard to find a strong correlation between dose and efficacy

E_L

or dose and toxicity for that matter, we saw no data on that i think

Bulder

It's based on the conclusion in the abstract

E_L

and you can be sure Genmab does know that data

E_L

yes, ok, me too

Bulder

didn't winkel comment on the liver-issue recently? or was that dr5/dr5?

E_L

"29/3 09:33
af Sukkeralf
The problem with 4-1BB was liver tox if I remember what Jan said at some point - so with these new attempts where you only get them attivated in the microenviroment of the solid tumours it should avoid liver tox"

E_L

i think he also asked Jan in a QA about dr5 / liver tox, but Jan didnt really answer

E_L

Jan can be quite good at not answering if he doesnt want

E_L

@GB 17:06 don't forget that he always knows more then we do

E_L

(and that he has a lot more share then we do )

E_L

(and sometimes then should be than )

Klarussen

@Mogan, jeg er knap 100% kontant, solgte ud før præsidentvalget i US. Har ikke haft Genmab nogle måneder og venter på godt entrypoint. Tror vi skal længere ned i hele markedet , 2150 er bare et fiktivt tal, men i det område køber jeg gerne igen. Tror meget stærkt på Genmab på den lange bane.

Klarussen

Har været inde og ude af Genmab en del gange, og tjent godt, men ville ønske jeg bare havde holdt fast fra starten og haft Helges kølige overblik

Helge_LarsenPI-redaktør

Aktier: USA-frygtindeks ligger højt, men langt fra corona-tophttps://www.proinvestor.com/investornyt/669481/aktier-usa-frygtindeks-ligger-hojt-men-langt-fra-corona-top

Klarussen

Men vi bevarer det kølige overblik

Helge_LarsenPI-redaktør

NBI: https://indexes.nasdaqomx.com/Index/Overview/NBI

Legolas23

NBI er en indikator og virker ikke ind på Genmab.